Organization (Academic)
University of the Punjab
ClinicalTrials.gov lists University of the Punjab as lead sponsor of 19 trials. It has 20 active development programs and 1 approved asset.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers University of the Punjab: 19 lead-sponsored trials and 1 legal-entity registration.
Disease areas (29)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Child Nutrition Disorders | 3 |
| Diabetes Mellitus | 3 |
| Malnutrition | 3 |
| Athletic Injuries | 1 |
| Cognitive Dysfunction | 1 |
Showing 5 of 29 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 4 |
| 2019 | 1 |
| 2015 | 1 |
| 2012 | 5 |
Showing 10 of 11 years.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (20)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| PRP + ASCs injection | Diabetic Neuropathies | Phase 1 | 1 |
| PRP + ASCs injection | Diabetic Foot | Phase 1 | 1 |
| Cultured ASCs enrichment fat grafting | Facial Hemiatrophy | Phase 1 | 1 |
| Cultured ASCs enrichment fat grafting | Goldenhar Syndrome | Phase 1 | 1 |
| PRP + ASCs injection | Diabetes Mellitus | Phase 1 | 1 |
Showing 5 of 20 active programs.
Approved assets (1)
| Drug | Trials |
|---|---|
| Calcium/Vitamin D | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 3 hit target (n=3) | 1 of 3 on time (n=3) |
Journals published in (33)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Diabetes research and clinical practice | 2 |
| Stem cells translational medicine | 2 |
| American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics | 1 |
| Angiology | 1 |
| BMC pregnancy and childbirth | 1 |
Showing 5 of 33 journals.
Organization relationships (3)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Higher Education Commission | Co sponsors trial with | 1 |
| Jinnah Burn and Reconstructive Surgery Centre, Lahore | Co sponsors trial with | 1 |
| Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore. | Co sponsors trial with | 1 |
Latest dated events (25)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-04-21 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-03-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-03 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 25 events.
Biomarker capability evidence (4)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CEBPA | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted without stated criteria (ClinVar) |
| NPM1 | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted without stated criteria (ClinVar) |
| RUNX1 | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted without stated criteria (ClinVar) |
| TP53 | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted without stated criteria (ClinVar) |
Biomarkers this organization publishes on (102)
Shown in this order: most publications first.
Showing 5 of 102 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.